The Emergency Department is the first line of defense against sepsis, which is a progressive and time-sensitive medical emergency. CMS 3-hour bundle requirements begin at time of triage in the ED.4 Fluid resuscitation should be initiated immediately.5
When every moment counts, access to advanced dynamic and flow-based parameters offers valuable insight to help you guide proactive volume administration decisions.3
Edwards Lifesciences’ advanced hemodynamic monitoring solutions can help you detect sepsis symptoms early, help guide therapy and assessment of fluid responsiveness and comply with CMS/NQF bundle guidelines.3,6-7
It is critically important that your patients are diagnosed as soon as possible and receive the appropriate, intensive care. Wide variability in the hemodynamic profiles of septic patients can complicate early diagnosis and treatment evaluation.
Edwards offers advanced hemodynamic monitoring solutions that clinicians can tailor based on each patient’s physiological needs to help proactively manage sepsis, severe sepsis and septic shock.3
SV, SVV, SVR, CO, cBP
The ClearSight finger cuff can be used to measure flow-based parameters continuously prior to, during, and after the fluid administration portion of the 3-hour CMS sepsis bundle. The ClearSight finger cuff connects quickly and noninvasively to a broad patient population, including the elderly or obese.8-10 It can be used to test fluid responsiveness with a fluid challenge and passive leg raise for patients not mechanically ventilated. Continuous blood pressure, CO and SV provide actionable information about sensitive changes in preload.8
The EV1000 clinical platform presents the physiologic status of your patient in an intuitive and meaningful way. Color-based indicators communicate patient status at a glance, and visual clinical support screens allow for immediate recognition and increased understanding of rapidly changing clinical situations, to help you make more informed assessments of fluid responsiveness. Designed in collaboration with and validated by clinicians, the EV1000 clinical platform offers you scalability and adaptability throughout the continuum of care, from the ED to the OR and ICU.
The sepsis bundle guidelines as presented, were published by CMS on August 4, 2014 and are presented for informational purposes only. This information does not constitute reimbursement or medical advice. Edwards makes no representation or warranty regarding this information or its completeness, accuracy or timeliness. It is not intended to make a recommendation regarding clinical practice. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to clinical services, coding and reimbursement submissions. Accordingly, Edwards strongly recommends consultation with CMS, payers, reimbursement specialists and/or legal counsel regarding guidelines, coding, coverage, and reimbursement matters.
Caution: Federal (United States) law restricts this device to sale by or on the order of a physician.
See Instructions For Use (IFU) / Directions For Use (DFU) for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.
Please update to a current version of your preferred browser, this site will perform effectively on the following:Unable to update your browser?
If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility